1. Butler M, Pongor L, Su YT, Xi L, Raffeld M, Quezado M, Trepel J,Aldape K, Pommier Y, Wu J. MGMT Status as a Clinical Biomarker in Glioblastoma. Trends Cancer. 2020 May;6(5):380-391.
2. Rao AM, Quddusi A, Shamim MS. The significance of MGMT methylation in Glioblastoma Multiforme prognosis. J Pak Med Assoc. 2018 Jul;68(7):1137-1139.